Coronavirus Media ArticlesExcerpts of Key Coronavirus Media Articles in Major Media
Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
Moderna CEO StÄ‚©phane Bancel more than tripled the number of his company shares to be sold through an executive stock plan that was changed just days after the biotech in May announced positive early results for its coronavirus vaccine. Moderna's shares spiked on the May news, rising 30% in just one day. After seeking the executive stock plan change in May, Bancel sold more than 72,000 Moderna shares in the first 16 days of July, generating nearly $4.8 million for the executive. That was more than triple the 22,000 shares he had previously scheduled to sell during the same period through the company's executive trading plan. Another top Moderna executive, President Stephen Hoge, also had his pre-programmed executive trading plan reset around the same time. The change allowed him to sell $1.9 million worth of Moderna stock in the first two weeks of July. The executives' ... sales were made through what are known as 10b5-1 stock plans. These arrangements must be set up or amended at least 30 days before any transactions are executed; they are commonly used at publicly traded companies to help shield executives from potential claims of insider trading. The fact that the plans were changed during the pandemic as news was emerging about the company's closely watched coronavirus vaccine raises new questions about how Moderna executives have pocketed millions of dollars in recent months.
According to a July 17 study published in the International Journal of Geriatrics and Rehabilitation, 50 percent of nucleic acid coronavirus tests distributed by the Centers for Disease Control and Prevention (CDC) provided inaccurate results. The study's lead author, Sin Hang Lee, MD, director of Milford Molecular Diagnostics Laboratory, found that the testing kits gave a 30 percent false-positive rate and a 20 percent false-negative rate. To determine these false-positive and false-negative rates, the Connecticut State Department of Public Health Microbiology Laboratory provided Lee 20 tests, which were then re-tested using his own methodology, which examines samples on a cellular level, rather than just testing fluid with no cellular matter from potentially infected oral and nasal secretions. While the results of Lee's testing may be alarming, they also pointed to yet another discovery: new mutations of the virus. Two tests that initially provided false-negatives and one test that yielded a positive result were actually found to be positive for coronavirus and a mutation of the virus, meaning two variants of the virus can simultaneously infect one person. However, it's not just the test you use that may be contributing to inaccurate results—when you get tested is important, too. Getting tested the day a person is infected with coronavirus will likely yield a 100 percent false-negative rate; by day 8 after becoming infected, however, that rate drops to just 20 percent.
Note: Explore an excellent, well-researched article further questioning the validity of these tests. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
Sweden’s decision to keep schools open during the pandemic resulted in no higher rate of infection among its schoolchildren than in neighboring Finland, where schools did temporarily close, their public health agencies said in a joint report. Sweden decided to forego a hard lockdown and keep most schools and businesses open throughout the COVID-19 outbreak, a divisive strategy that set it apart from most of Europe. Its Public Health Agency has maintained that the negative consequences of a shutdown on the economy and society outweigh the benefits, and says this also applies to schools. During the period of February 24 to June 14, there were 1,124 confirmed cases of COVID-19 among children in Sweden, around 0.05% of the total number of children aged 1-19. Finland recorded 584 cases in the same period, also equivalent to around 0.05%. “In conclusion, (the) closure or not of schools had no measurable direct impact on the number of laboratory confirmed cases in school-aged children in Finland or Sweden,” the agencies said in the report. Sweden’s death toll of 5,572, when compared relative to population size, far outstripped those of its Nordic neighbors, although it remains lower than in some European countries that locked down, such as Britain and Spain. State epidemiologist Anders Tegnell of the health agency, who has devised Sweden’s response to the epidemic, has said there is little evidence linking the death toll to the absence of a lockdown.
Note: Explore an excellent article on Sweden's underreported success in dealing with COVID-19. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
More than a million people may have quit smoking in Britain during the pandemic, figures have suggested. A survey of 10,000 people indicated that across the country as many as 400,000 people aged 16 to 29 dropped their smoking habit during lockdown, and 240,000 aged over 50. It is believed another 400,000 aged 30-49 have also quit since April, according to analysis by the charity Action on Smoking and Health and University College, London. It is thought to be explained by the health threat, as Covid-19 has severe effects on the respiratory system. A public health drive is now being launched to encourage more people to give up smoking. The figures have been published to coincide with a new campaign, funded by the Department of Health and Social Care, which hopes to target smokers in areas with the highest rates of smoking, such as England's north east. Matt Hancock has set a Government target for the UK to become smoke-free by 2030. Deborah Arnott, the chief executive of ASH, said: "This campaign is designed to encourage those who have not yet succeeded in stopping to wake up, and decide that today is the day to stop smoking." Dr Ruth Sharrock, a respiratory consultant who is supporting the campaign, said: “Every day of my working life I see the terrible health problems caused by smoking. But I have also been inspired by those already suffering from smoking related diseases, who have still managed quit and get health benefits from this.”
Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
As America begins the formidable task of getting our kids back to school and all of us back to work safely ... public health experts face two opponents: covid-19, but also political leaders and others attempting to undermine the Centers for Disease Control and Prevention. As of this date, the CDC guidelines, which were designed to protect children, teachers, school staffers and their families — no matter the state and no matter the politics — have not been altered. It is not unusual for CDC guidelines to be changed or amended during a clearance process that moves through multiple agencies and the White House. But it is extraordinary for guidelines to be undermined after their release. Through last week, and into Monday, the [Trump] administration continued to cast public doubt on the agency’s recommendations and role in informing and guiding the nation’s pandemic response. On Sunday, Education Secretary Betsy DeVos characterized the CDC guidelines as an impediment to reopening schools quickly rather than what they are: the path to doing so safely. The only valid reason to change released guidelines is new information and new science — not politics. Sound science is being challenged with partisan potshots, sowing confusion and mistrust. These efforts have even fueled a backlash against public health officials: Public servants have been harassed, threatened and forced to resign when we need them most.
A leading epidemiologist says "thousands of people" will be quarantined in isolation facilities for months - and possibly years - into the future. University of Otago professor of public health Michael Baker's appearance on Newshub Nation on Saturday comes after multiple cases of people breaking out of their facilities. Prof Baker says ... we need to be prepared for a "long-term risk management challenge". "Mistakes happen, and we have to learn from them and improve our systems so we don't repeat those errors," he [said]. "We're going to have thousands of people sitting in these facilities, quarantined in isolation facilities for months, maybe years ahead." The latest escapee, a person in their 60s, broke the window of the Waipuna Hotel in Auckland on Friday and climbed out of the building. Their escape is the fourth since last Saturday, when a woman scaled two fences to escape from Auckland's Pullman Hotel. On Tuesday, a 32-year-old man snuck through a gap in the Stamford Plaza fencing and visited an inner-city supermarket. Prof Baker says we need to look at why these people feel the need to escape from the isolation facilities. ACT leader David Seymour said the Government needs to start profiling travelers based on their risk of absconding. "The vast majority of people entering New Zealand will pose absolutely no risk of absconding from managed isolation and quarantine facilities," he said in a statement. "But a tiny minority will be a risk. The Government should ... place them under tighter security."
Note: Baker likely is not referring to individuals being detained for years, but to these policies continuing for years. A second MSN article includes a video describing how police are now guarding the quarantine facilities in New Zealand, which is being called "managed isolation." The "managed isolation" aka quarantine policy started in April. As this article states, "every person arriving in New Zealand will have to go into compulsory quarantine as a measure to try and combat Covid-19." For more, see summaries of revealing news articles on the coronavirus from major media sources.
Scientists have devised a way to use the antibody-rich blood plasma of COVID-19 survivors for an upper-arm injection that they say could inoculate people against the virus for months. Using technology that's been proven effective in preventing other diseases such as hepatitis A, the injections would be administered to high-risk healthcare workers, nursing home patients, or even at public drive-through sites. But the idea exists only on paper. Federal officials have twice rejected requests to discuss the proposal, and pharmaceutical companies — even acknowledging the likely efficacy of the plan — have declined to design or manufacture the shots. The antibodies in plasma can be concentrated and delivered to patients through a type of drug called immune globulin, or Ig, which can be given through either an IV drip or a shot. Yet for the coronavirus, manufacturers are only developing an intravenous solution of Ig. Intravenous plasma products are traditionally the main economic driver for the industry. The money-making antibodies are also far more diluted in intravenous drugs than in injectable ones, which boosts profit margins. “They charge a fortune off of intravenous drugs in the hospital. They don't want to devote the manufacturing plant to something that won't make oodles of money,” said one infectious disease expert. Researchers also said industry executives have little incentive to produce the immunity shots for the coronavirus, given the possibility that a longer-lasting vaccine could replace it within a year.
Disruption to food production and supplies due to COVID-19 could cause more deaths from starvation than the disease itself, according to an Oxfam report. The report found that 121 million more people could be “pushed to the brink of starvation this year” as a result of disruption to food production and supplies, diminishing aid as well as mass unemployment. The report estimates that COVID-19 related hunger could cause 12,000 deaths per day: the peak global mortality rate for COVID-19 in April was 10,000 deaths per day. “COVID-19 is the last straw for millions of people already struggling with the impacts of conflict, climate change, inequality and a broken food system that has impoverished millions of food producers and workers,” said Oxfam’s Interim Executive Director Chema Vera. Oxfam says Yemen, Democratic Republic of Congo (DRC), Afghanistan, Venezuela, the West African Sahel, Ethiopia, Sudan, South Sudan, Syria, and Haiti are “extreme hunger hotspots” that are likely to be severely affected by the pandemic. Women, who also make up a significant portion of informal workers, are more likely to have been severely affected by lockdown measures. The report notes that there are enough funds globally to address starvation. Eight out of ten of the biggest food and drink companies paid more than $18 billion to shareholders since the beginning of this year, an amount that is “ten times more than the UN says is needed to stop people going hungry,” according to the report.
Since June 19, when new cases in the United States went back over 30,000 in one day, we have been constantly bombarded with stories of how the virus is “spiking” in “record” numbers in many of the states (like California, Texas, Florida and Arizona) that were not hit hard in the “first wave.” Across the country, our number of new cases has indeed exploded to new levels during this time period ... and the news media, both at the national and local levels, have used these statistics to essentially create panic porn. The resulting public anxiety has caused several states to reverse their reopenings. Obviously the “new case” data point is both real and relevant, but it is also now extremely misleading. By incompetently using the same measure of what a “positive” virus test meant in April, to what it now means in July, the news media is in the process of, quite effectively, sabotaging America’s recovery from this crisis. The data ... now makes it overwhelmingly obvious that nowhere near as many people who recently tested positive for the virus are going to die as did when this nightmare began. While the development has gotten scandalously little news coverage, the daily numbers of deaths with/of COVID has been declining with remarkable consistency for well over two months now. Sweden, a country much maligned in the media because they dared to not lock down by government mandate, has “new case” and “death” charts which look remarkably similar to ours. Their daily death rate has recently been down to single digits.
Note: Don't miss this entire article which pulls back the curtain on media manipulations in these challenging times. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and media manipulation from reliable major media sources.
Forty lobbyists with ties to President Donald Trump helped clients secure more than $10 billion in federal coronavirus aid. The lobbyists identified Monday by the watchdog group Public Citizen either worked in the Trump executive branch, served on his campaign, were part of the committee that raised money for inaugural festivities or were part of his presidential transition. Many are donors to Trump’s campaigns. Trump pledged to clamp down on Washington's influence peddling with a “drain the swamp” campaign mantra. But during his administration, the lobbying industry has flourished, a trend that intensified once Congress passed more than $3.6 trillion in coronavirus stimulus. While the money is intended as a lifeline to a nation whose economy has been upended by the pandemic, it also jump-started a familiar lobbying bonanza. Shortly after Trump took office, he issued an executive order prohibiting former administration officials from lobbying the agency or office where they were formerly employed, for a period of five years. Another section of the order forbids lobbying the administration by former political appointees for the remainder of Trump's time in office. Yet five lobbyists who are former administration officials have potentially done just that during the coronavirus lobbying boom. Public Citizen's Craig Holman, who himself is a registered lobbyist, said the group intends to file ethics complaints with the White House. But he's not optimistic that they will lead to anything.
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors. The price was swiftly criticized; a consumer group called it “an outrage” because of the amount taxpayers invested toward the drug's development. In 127 poor or middle-income countries, Gilead is allowing generic makers to supply the drug; two countries are doing that for around $600 per treatment course. The drug, given through an IV, interferes with the coronavirus’s ability to copy its genetic material. In a U.S. government-led study, remdesivir shortened recovery time by 31% — 11 days on average versus 15 days for those given just usual care. Peter Maybarduk, a lawyer at the consumer group Public Citizen, called the price “an outrage.” “Remdesivir should be in the public domain” because the drug received at least $70 million in public funding toward its development, he said. “The price puts to rest any notion that drug companies will ‘do the right thing’ because it is a pandemic,” Dr. Peter Bach, a health policy expert ... said. “The price might have been fine if the company had demonstrated that the treatment saved lives. It didn’t.”
Note: The March coronavirus package passed in the U.S. "not only omitted language that would have limited drug makers’ intellectual property rights, it specifically prohibited the federal government from taking any action if it has concerns that the treatments or vaccines developed with public funds are priced too high." While many suffer economically from the virus, big Pharma is raking in big bucks. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and the coronavirus from reliable major media sources.
Pediatricians say students should be in classrooms for in-person learning as soon as possible – the most full-throated endorsement yet for getting children back into schools amid the coronavirus pandemic and one that was included in a set of recommendations released by the American Academy of Pediatrics for how schools should safely reopen. "The importance of in-person learning is well-documented, and there is already evidence of the negative impacts on children because of school closures in the spring of 2020," the group representing 67,000 pediatricians wrote. "Lengthy time away from school ... often results in social isolation, making it difficult for schools to identify and address important learning deficits as well as child and adolescent physical or sexual abuse, substance use, depression, and suicidal ideation. This, in turn, places children and adolescents at considerable risk of morbidity and, in some cases, mortality." The recommendations acknowledge that infectious disease experts are still learning about the effects of COVID-19. But the academic, physical and mental upsides associated with reopening outweigh the risks, the group concludes, especially as evidence mounts that children ... tend to exhibit milder symptoms when they do contract the virus. Perhaps most importantly, the pediatric group concludes, reopening is essential for the country's most vulnerable students, including poor students and students of color.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
Sweden's state epidemiologist Anders Tegnell has hit back at the World Health Organization after it included Sweden in a group of countries facing "a very significance resurgence" of coronavirus infections. Mr Tegnell, who has in recent months become one of the world's most high profile and divisive epidemiologists, said: "That is, unfortunately, a total misinterpretation of the data." "It's very unfortunate that people lump Sweden together with countries that earlier have had no problem at all and are now apparently at the start of their epidemic," he told Sweden's state broadcaster SVT. Hans Kluge, the WHO's Regional Director for Europe, on Thursday named Sweden in a list of eleven problem countries ... which are facing "accelerated transmission" of infection. Sweden has this month seen the daily number of confirmed cases more than triple from 60 on June 1st to 207 on Thursday. But Mr Tegnell argued that this has to do with increased testing rather than a resurgence in infection. "This is growing because we recently started offering tests to everyone with symptoms," he told Sweden's TT newswire. "We are doing twice as many tests as we were a few weeks ago. But the growth we are seeing is in mild cases, not hospital admissions." Mr Tegnell has drawn both admiration and criticism internationally for leading a coronavirus strategy that left schools for 14-16 year olds open throughout the pandemic, as well as bars, restaurants, gyms, and much else, relying instead on the public's willingness to follow social distancing guidelines.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
Confidence levels jumped in Sweden as consumers and businesses started to leave the worst of the Covid-19 crisis behind them. The overall economic tendency survey rose to 75.2 in June, from a revised 64.4 in May, the National Institute of Economic Research said Wednesday. Sentiment had plunged to an all-time low in April, and despite June’s jump remains depressed, as values below 90 are equivalent to a much weaker than normal economy. The reading comes as economists and policy makers revise up their forecasts in light of better-than-expected consumer spending and unemployment data. According to Manuel Oliveri, an FX strategist at Credit Agricole, the rebound in confidence levels “continues to keep the risk for additional policy action low, irrespective of Riksbank members leaving all options open.” But Bloomberg economist Johanna Jeansson was less sanguine, while agreeing that “the most acute phase of the crisis has abated.” “Today’s survey is yet another sign that the most acute phase of the crisis has abated. But with both demand and supply below pre-pandemic levels, we expect the Riksbank and the Ministry of Finance will have to do more,” [said] Johanna Jeansson. Unlike its neighbors, Sweden avoided a strict lockdown as the coronavirus spread, keeping shops, schools and restaurants open. The lax strategy appears to have mitigated some of the economic damage caused by the pandemic, but at the cost of a relatively high death toll.
Note: Meanwhile the IMF states that worldwide, economic contraction and soaring debt levels and unemployment are worse than earlier predicted. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
The Centers for Disease Control and Prevention is conflating the results of two different types of coronavirus tests, distorting several important metrics and providing the country with an inaccurate picture of the state of the pandemic. We’ve learned that the CDC is making, at best, a debilitating mistake: combining test results that diagnose current coronavirus infections with test results that measure whether someone has ever had the virus. The agency confirmed to The Atlantic on Wednesday that it is mixing the results of viral and antibody tests, even though the two tests reveal different information and are used for different reasons. This is not merely a technical error. The upshot is that the government’s disease-fighting agency is overstating the country’s ability to test people who are sick with COVID-19. States have set quantitative guidelines for reopening their economies based on these flawed data points. Several states - including Pennsylvania, the site of one of the country’s largest outbreaks, as well as Texas, Georgia, and Vermont - are blending the data in the same way. Virginia likewise mixed viral and antibody test results until last week, but it reversed course and the governor apologized for the practice. These results damage the public’s ability to understand what is happening in any one state. On a national scale, they call the strength of America’s response to the coronavirus into question. The number of tests conducted nationwide each day has more than doubled in the past month. At the same time, the portion of tests coming back positive has plummeted.
Prof Matteo Bassetti, head of the infectious diseases clinic at the Policlinico San Martino hospital in Italy, told The Telegraph that Covid-19 has been losing its virulence in the last month and patients who would have previously died are now recovering. The expert in critical care said the plummeting number of cases could mean a vaccine is no longer needed as the virus might never return. "The clinical impression I have is that the virus is changing in severity," said Prof Bassetti. "In March and early April the patterns were completely different. People were coming to the emergency department with a very difficult to manage illness and they needed oxygen and ventilation, some developed pneumonia. "Now, in the past four weeks, the picture has completely changed. There could be a lower viral load in the respiratory tract, probably due to a genetic mutation in the virus which has not yet been demonstrated scientifically. Even elderly patients, aged 80 or 90, are now sitting up in bed and they are breathing without help. The same patients would have died in two or three days before. "I think the virus has mutated because our immune system reacts to the virus and we have a lower viral load now due to the lockdown, mask-wearing, social distancing. "Yes, probably it could go away completely without a vaccine." Prof Karol Sikora ... at Rutherford Health previously said it is likely the British public has more immunity than previously thought and Covid-19 could end up "petering out by itself".
Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
Dr. Richard Bartlett works at various clinics around West Texas, and says he’s found a successful treatment for the coronavirus. “The treatment plan is inhaled, generic budesonide,” Bartlett said. “Using some generic antibiotics to protect from a secondary bacterial infection. Using zinc, which interferes with virus replication. It’s common sense. It’s intuitive.” Budesonide is a steroid, that can be inhaled directly to the lungs using a nebulizer. The drug has been used for decades to treat asthma and is approved by the FDA. However using it to treat COVID-19 is not. “I am not aware of any doctors anywhere that are using this specifically for COVID-19, yet,” Bartlett said. Bartlett said he treats people as soon as they show symptoms. “Early treatment is better with this disease,” he said. “And I’m having a 100% survival rate. I don’t even know how many I’ve treated...dozens. I have 14 that I’m treating right now.” Bartlett said that patients tell him they feel immediate relief. Bartlett said he’s currently writing a paper to submit to medical journals. Additionally, he said the National Institute of Health, as well as the countries of France and Spain will be looking into inhaled budesonide treatments.
Note: Watch a fascinating interview with this doctor. And remember that the biggest sponsor of the major media is big Pharma. The don't want any cheap medicine like hydrochlorequine or budesonide to look good. There are other inexpensive treatments that are not being reported. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
The Trump administration this month announced that one of its largest pandemic-related contracts would go to a little-known biodefense company named Emergent BioSolutions. The $628 million deal to help manufacture an eventual vaccine cemented Emergent's status as the highest-paid and most important contractor to the HHS office responsible for preparing for public health threats and maintaining the government's stockpile of emergency medical supplies. Emergent has long been the government's sole provider of BioThrax, a vaccine for anthrax poisoning. Emergent's advocacy for biodefense spending over more than a decade was aided by influential allies in Washington and tens of millions of dollars in lobbying campaigns. "It has strategically placed itself to be, let's just say, the company that can't fail," said a former senior government official who worked with Emergent on stockpile operations. The company that would become Emergent began as BioPort Corp., formed in 1998 to buy an aging, state-owned company in Lansing, Mich., that was the only licensed supplier of anthrax vaccine to the Pentagon. The Pentagon ... awarded a $29 million no-bid contract for the anthrax vaccine, BioThrax. Controversy swamped the operation. Hundreds of U.S. troops who received the BioThrax treatment complained of bad reactions, such as headaches and nerve problems. Some troops risked courts-martial by refusing vaccination. Emergent spent nearly $4 million on lobbying last year alone.
Note: To understand the huge influence of lobbying and profits on the development and stockpiling of vaccines, don't miss reading this entire, eye-opening article. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and vaccines from reliable major media sources.
How accurate are the coronavirus tests used in the U.S.? Months into the outbreak, no one really knows. When the new virus began spreading, the Food and Drug Administration used its emergency powers to OK scores of quickly devised tests, based mainly on a small number of lab studies showing they could successfully detect the virus. That’s very different from the large patient studies that can take weeks or months, which experts say are needed to provide a true sense of testing accuracy. There have been more than 2 million confirmed coronavirus cases in the U.S. and more than 115,000 deaths. Cases in nearly half of U.S. states are rising. Most COVID-19 tests in the U.S. don’t give data on real-world performance, including how often the tests falsely clear patients of infection or falsely detect the virus. That information is lacking for all but a few of the roughly 80 commercial screening tests available. Last month, the FDA warned doctors of a potential accuracy problem with Abbott Laboratories’ rapid ID Now test, which delivers results in roughly 15 minutes. The test has been lauded by President Donald Trump and used to screen the president, his staff and visitors to the White House. The FDA alert followed a preliminary report by New York University that found Abbott’s test missed between a third to one-half of infections caught by a rival test in patients screened for the virus. Dr. Colin West of the Mayo Clinic worries doctors and patients have put too much confidence in the current crop of tests.
Remember the coronavirus? We were told by public health experts ... that we could not go outside for any reason. Roughly two weeks ago, everything changed. We all watched as mass stay-at-home orders and self-isolation gave way to massive street protests, where tens or hundreds of thousands of people gathered together in the U.S. and around the world. Virtually no prominent experts have denounced any of this on the ground that it will spread the coronavirus and ultimately kill more people. To the contrary, many infectious disease experts have done the exact opposite: they have endorsed and encouraged these mass street protests, claiming not that their support for them is grounded in their political values but in their health and scientific judgment. Perhaps the most egregious and illustrative example of the utter manipulation of public health science and expertise for nakedly political ends is found in the open letter that was originally crafted by epidemiologists at the University of Washington and then ultimately signed by 1,300 experts from around the country. These health experts ... decree that support for these protests is mandated as a matter of public health and scientific expertise, while imperiously insisting that other protests should still be scorned and prohibited. How is it remotely within the scope of the expertise of epidemiologists to pick and choose which political protests should be permitted and/or encouraged and which ones banned and/or denounced?
Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.